Public Company News
Keymed Biosciences Announces 2025 Annual Results and Business Updates
BEIJING, March 26, 2026 /PRNewswire/ -- Keymed Biosciences (HKEX: 02162) announced its 2025 annual results. The year marked the company's 10th anniversary and a pivotal year in its transition from R&D to commercialization. Revenue Leaps Forward, Supporting Long-Term Stable Growth Since its found...
CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0
Rapid Advancement Across Core R&D Pipeline * The global, multicenter Phase I/II clinical trial of CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) is actively enrolling patients in Australia and China, and the Phase II IND application has been approved in the US. CS2009 demonstrates an excellent...
Neurophet Signs MOU with ALZ-NET to Facilitate Imaging Monitoring Infrastructure for Alzheimer's Disease Therapies
* Aims to improve quality of care for patients with Alzheimer's disease… Exploring adoption of Neurophet's key solutions * Collaboration expected to leverage Neurophet AQUA, Neurophet SCALE PET and Neurophet AQUA AD Plus SEOUL, South Korea, March 26, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Ja...
Addentax Group Corp. Announces Reverse Stock Split
SHENZHEN, China, March 26, 2026 /PRNewswire/ -- Addentax Group Corp. (Nasdaq: ATXG) (the "Company") announced today that following the stockholder approval of the reverse stock split proposal at the Company's 2025 Annual Meeting of Stockholders held on January 30, 2026, the Board of Directors of ...
CStone Updated Clinical Progress and Key Phase I/II Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)
Key Highlights: * Excellent Safety Profile: As of mid-March 2026, 113 heavily pretreated patients with solid tumors have been enrolled in the Phase I trial of CS2009, with a median follow-up of approximately 6 months. The more mature data continue to show a favorable safety profile, with23% i...
Peijia Medical Announces 2025 Annual Results
SUZHOU, China, March 26, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced its annual results for the year ended December 31, 2025 on March 25, 2026. During th...
Samsung Biologics Recognized for Advancing Sustainability at 2026 CDMO Leadership Awards
* Reinforcing long-term commitment to embedding sustainability across operations and partnerships * Continuing to support clients in delivering high-quality, life-saving medicines to patients worldwide INCHEON, South Korea, March 26, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a ...
Highway Holdings Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
HONG KONG, March 26, 2026 /PRNewswire/ -- Highway Holdings Limited (Nasdaq: HIHO, the "Company" or "Highway Holdings") today announced that on March 17, 2026,Highway Holdings Limited (the "Company") received a written notification (the "Notification Letter") from the Listing Qualifications Depart...
Innovent Announces 2025 Annual Results and Business Updates
From China Leadership to Global Premier: Revenue Surpasses RMB 10 Billion, Entering the Era of Profitability and Globalization SAN FRANCISCO and SUZHOU, China, March 26, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develop...
GC Biopharma Receives Marketing Authorization for Varicella Vaccine 'BARYCELA Inj.' in Guatemala
- First regulatory clearance in Latin America marks a strategic milestone for regional market expansion - World's first antibiotic-free manufacturing process ensures superior safety profile YONGIN, South Korea, March 26, 2026 /PRNewswire/ -- GC Biopharma(006280.KS), a leading provider of biophar...
LG Leadership Emphasizes 'Speed' as the Core Driver in the AX Era
SEOUL, South Korea, March 26, 2026 /PRNewswire/ -- LG hosted a President's
Meeting on the 25th at the Namsan Leadership Center in Seoul, attended by LG
Corp. Chairman and CEO Kwang-mo Koo and about 40 top executives from major
affiliates.
Hengrui Pharma Announces Strong 2025 Annual Results
SHANGHAI, March 25, 2026 /PRNewswire/ -- On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled by its dual strategy of innovation and globalization. Revenue increased 13% year-on-year to RMB 31.63 billion, and net profit attribut...
Health In Tech Announces $7.0 Million Private Placement
STUART, Fla., March 25, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced that it has entered into a securities purchase agreement for a private investment in public equity financing (the "PIPE") ...
X Financial Reports Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results
SHENZHEN, China, March 25, 2026 /PRNewswire/ -- X Financial (NYSE: XYF), a leading Chinesefintech platform, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. This press release should be read in conjunction with the Company's Report on...
OLLOBOT Prepares August Kickstarter Launch for Enhanced OlloNi Following Strong CES 2026 Debut
LAS VEGAS, March 25, 2026 /PRNewswire/ -- OLLOBOT,
RoboSense Beat Expectations, Achieved First-Ever Quarterly Profit on Strong Robotics Growth
* Achieved the first-ever quarterly net profit in Q4 2025, reaching approximately RMB 104 million, significantly exceeding market expectations. * Quarterly LiDAR sales volume for robotics and others experienced explosive growth in Q4 2025, with total shipments reaching approximately 221,200 un...
Clarity signs a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics
SYDNEY, March 25, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a lar...
GIBO Expands GIBO Watch with "Digital Canvas" -- A Next-Generation Generative Pipeline for Short Film Creation
KUALA LUMPUR, Malaysia, March 25, 2026 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO), a global technology company focused on AI-driven content infrastructure, today announced the launch of the"Digital Canvas" within its GIBO Watch framework—a next-generation generative pipeline designed to em...
K-Beauty Manufacturer KM Pharmaceutical (KOSDAQ: 225430) Expands Global Skincare and Oral Care OEM/ODM Platform with Advanced Functional Product Portfolio
SEOUL, South Korea, March 25, 2026 /PRNewswire/ -- KM Pharmaceutical Co., Ltd. (KOSDAQ: 225430), a leading K-beauty manufacturer specializing in skincare, oral care, and private label OEM/ODM production, is strengthening its global position by expanding into high-value functional product categori...
TOYO Co., Ltd Schedules Second Half and Fiscal Year 2025 Earnings Release and Conference Call Date
TOKYO, March 25, 2026 /PRNewswire/ -- TOYO Co., Ltd
Week's Top Stories
Most Reposted
Tonik Becomes the First Standalone Digital Bank in the Philippines to Achieve Profitability
[Picked up by 297 media titles]
2026-05-12 10:15Visa amps up the music as Official Payment Partner for the Asia leg of The Weeknd's 'After Hours Til Dawn' Stadium Tour
[Picked up by 293 media titles]
2026-05-11 16:20Avnet and HKSTP Invite Global Startups to New AI Hardware Launchpad
[Picked up by 290 media titles]
2026-05-12 10:00Peach Blossoms Celebrates Three Massive Wins - Black Pearl Restaurant Guide 2026, Asia's 50 Best Restaurants 2026 Extended List and Tatler Best 20 Restaurants in Singapore 2026
[Picked up by 283 media titles]
2026-05-12 14:00Amity's Singapore-Headquartered AI Research Center Wins Gold at Taiwan's 2026 Best AI Awards
[Picked up by 280 media titles]
2026-05-13 08:00